Home Community PET [(11)C]Choline PET/CT in Prostate Cancer Patients with Biochemical Recurrence after Radical Prostatectomy

[(11)C]Choline PET/CT in Prostate Cancer Patients with Biochemical Recurrence after Radical Prostatectomy

Communities
Use of [11C]choline PET/CT in prostate cancer (CaP) imaging has demonstrated mixed results. The usefulness of labeled choline in cancer imaging is based upon the fact that the rate limiting enzyme choline kinase and the specific choline transporter are upregulated to support increased cell proliferation and concomitant membrane forming with major components being various phospholipids. Dr. Ludwig Rinnab and associates reported their experience with [11C]choline PET/CT staging of CaP in the online edition of the World Journal of Urology.

A retrospective study of 41 patients without evidence of lymph node or distant metastasis was performed. Mean age was 64.9 years and all had a rising PSA after radical prostatectomy (RP). Nine had received adjuvant radiotherapy and were identified by 3 consecutive rises in the PSA level. All patients had PSA measured on the day of [11C]choline PET/CT imaging and the mean was 2.8ng/ml. Imaging assessment was performed in a blinded fashion. TRUS was also performed in all patients.

In patients with pathological [11C]choline PET/CT uptake, PSA was 3.1ng/ml, and in those with a negative scan it was 0.86ng/ml. In 6 of 12 men with a PSA <1.5ng/ml, [11C]choline PET/CT showed a pathological uptake and a positive histology was found in 6/12 of these patients. In patients with a PSA between 1.5 and 2.5ng/ml, [11C]choline PET/CT showed a pathologic pattern in 16/16 and a positive histology was found in 12/16. In patients with a PSA between 2.5 and 5ng/ml, [11C]choline PET/CT showed a pathologic pattern in 8/8 and a positive histology was found in 7/8. In patients with a PSA greater than 5ng/ml, [11C]choline PET/CT showed a pathologic pattern in 5/5 and a positive histology was found in all. The sensitivity was 93% and the positive predictive value was 80%. The overall accuracy was 78%. The sensitivity for a PSA level <2/5ng/ml was 89%, with a specificity of 40%. Five patients had no [11C]choline PET/CT uptake and in 2 of these TRUS guided biopsy showed cancer. TRUS was suspicious in 26 patients and 20 had positive histology. Eleven other patients had a negative TRUS and 8 of them had a positive histology.

Source: UroToday
Trackback(0)
Comments (0)Add Comment

Write comment
smaller | bigger

busy
 

Related Articles

PET Products

PET Companies

PET Join Group

Description: Keep up-to-date with news, discussions, and network with thought leaders regarding positron-emission tomography.
Created: August 25, 2009, 5:43 pm
Owner: Christiaan van den Hout

Latest News

March 20, 2010, 11:48 am By Deepa Lantheus Medical Imaging Presents PET Imaging Agent Lantheus Medical Imaging, Inc. the company’s novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at t...
March 20, 2010, 10:36 am By Deepa PET/CT Helpful in Laparoscopic Lymphadenectomy GE Healthcare was recently named one of five companies to receive the Zenith Award from the American Association for Respiratory Care (AARC). Read more....
March 19, 2010, 11:10 am By Deepa FDG-PET for Vulvar Carcinoma Diagnosis Positron emission tomography (PET) can play a useful diagnostic role for patients with vulvar carcinoma, researchers said at the Society of Gynecologic Oncologists (SGO) 41st Annual Meeting on Women's...
March 19, 2010, 9:00 am By Deepa PET/CT for Detects Neuroendocrine Tumours Metastases PET/CT Best Imaging Method for Detecting Neuroendocrine Tumours Metastases to the Heart, researchers presented at the 7th Annual European Neuroendocrine Tumor Society (ENETS) Conference. Read more....
March 17, 2010, 10:56 am By Deepa Alzheimer's Early Detection With PET Scan Westside Medical Associates of Los Angeles and Westside Medical Imaging (WMI) of Beverly Hills announce the benefit of early positron emission tomography (PET) scanning to identify Alzheimer's in its ...
Discussions in PET

Paul Keough
November 2, 2009, 1:43 pm ASTRO Sun Nov 1st: Integrating New and Emerging Modalities into Radiation Therapy Daivd Kirsh, MD, PhD, gave an excellent presentation, comment on your thoughts on these topics he raised:How FDG-PET can be used to predict outcome to radiation therapy?  

Paul Keough
October 5, 2009, 1:42 pm When is PET the best choice for visualization? Given all the imaging choices available, when is the best quality, price, radiation exposure, to use PET?
Comments in PET
No Comments added yet.
Members
View all